This is not the most recent version of the article. View current version (12 NOV 2014)

Intervention Protocol

Chinese medicinal herbs for treating diabetic kidney disease

  1. Yutong Fei1,
  2. Hong Yang2,
  3. Congcong Wang1,
  4. Xia Tian1,
  5. Yinghui Wang3,
  6. Li Zheng4,
  7. Xiangyu Guo5,
  8. Yanke Ai6,
  9. Jian Ping Liu1,*

Editorial Group: Cochrane Renal Group

Published Online: 24 JAN 2007

Assessed as up-to-date: 25 JUN 2014

DOI: 10.1002/14651858.CD006336


How to Cite

Fei Y, Yang H, Wang C, Tian X, Wang Y, Zheng L, Guo X, Ai Y, Liu JP. Chinese medicinal herbs for treating diabetic kidney disease (Protocol). Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD006336. DOI: 10.1002/14651858.CD006336.

Author Information

  1. 1

    Beijing University of Chinese Medicine, Centre for Evidence-Based Chinese Medicine, Beijing, China

  2. 2

    Beijing University of Chinese Medicine, Graduate School, Beijing, China

  3. 3

    Beijing Royal Integrative Medicine Hospital, Department of Endocrinology and Renal Disease, Beijing, China

  4. 4

    Xiyuan Hospital of China Academy of Chinese Medical Sciences, Surgical Department, Beijing, China

  5. 5

    Dongfang Hospital of Beijing University of Chinese Medicine, Department of Endocrinology, Beijing, China

  6. 6

    The China Academy of the Chinese Medical Sciences, Institute of Basic Research in Clinical Medicine, Beijing, China

*Jian Ping Liu, The Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen, DK-2100, Denmark. jianping_l@hotmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 24 JAN 2007

SEARCH

This is not the most recent version of the article. View current version (12 NOV 2014)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

Our objective was to assess the beneficial therapeutic effects and risks of Chinese herbal medicines for treating people with type 2 DKD.